Newsletter

Blue Chip Stocks

How To Read a Balance Sheet As An Investor: The 7 Questions Prudent Investors Need to Ask!

Knowing how to read a balance sheet is a key skill investors need to know, because the balance sheet is the most underrated document in an annual report. Most new investors skip straight to earnings - perhaps not knowing how importance the balance sheet is or having an appreciate but not knowing how to read…

ByNick SundichApril 21, 2026

Its Deja Vu For Big Four Bank Investors As The Mortgage Wars Recommence With a Vengence!

Big Four Bank Investors may think they've seen the 'Mortgage Wars' all before and they're no big deal. After all: Aren't the banks always competing hard for borrowers whatever interest rates do? Yes, but the mortgage wars of 2022-23 were not called 'wars' for no reason. ANZ's resurrection of cashback retention payments, Westpac's latest fixed-rate…

ByNick SundichApril 21, 2026

Phase 1 of The ASX’s CHESS System Went Live Without a Hitch! But Unfortunately, The Job’s Not Done Just Yet

After a decade of delays, a A$250m write-off, regulatory lawsuits, and a CEO departure, Release 1 of the ASX's CHESS system went live this morning. It is a genuinely significant milestone. For a project that first entered planning in 2016, burnt through one vendor, wrote off a quarter of a billion dollars, attracted ASIC litigation, and…

ByNick SundichApril 20, 2026

Omni Bridgeway (ASX:OBL): Up 20% This Year Off The Back of Litigation Financing!

Omni Bridgeway (ASX:OBL) occupies one of the most unusual niches in global capital markets. It is not a law firm, nor a traditional investment manager, nor a credit provider in the conventional sense. Instead, it sits at the intersection of legal process, capital allocation, and risk underwriting. The company funds litigation and arbitration claims in…

ByNick SundichApril 20, 2026

Are These 10 ASX Stocks With Low PE Multiples Buying Opportunities?

Last week we looked at ASX stocks with high PE multiples, and this week we're taking a look at ASX Stocks With low PE multiples. Low P/E multiples are often treated as shorthand for value, although the reality is more nuanced. A compressed multiple can reflect genuine undervaluation, where the market underestimates the durability of…

ByNick SundichApril 20, 2026

The Chinese Economy In 2026 Has Vastly Changed Compared to Years Gone By: Here’s What It Means for the ASX!

The Chinese economy in 2026 is at one of the most consequential turning points since its WTO accession in 2001. The country is no longer the hyper‑growth engine that powered the global commodity supercycle, nor is it collapsing under the weight of its property downturn as some commentators suggest. Instead, China is transitioning into a…

ByNick SundichApril 17, 2026

These 8 ASX Growth Stocks Have High P/Es

If you're looking at ASX Growth Stocks with high P/Es you have two choices. First, you could write certain companies off just because of high multiples, only to lose out when such companies continue to grow. Alternatively, you could jump in and risk the company falling and be left red faced - 'If only I'd…

ByNick SundichApril 17, 2026

ASML (NASDAQ:ASML) Q1 sales +15%, but system shipments slowed and stock fell 7%

Net orders beat revenue 1.2x, yet investors punished machine sales ASML (NASDAQ:ASML) sits at the centre of the semiconductor supercycle and remains one of the most important companies in global chip development. Its lithography machines are fundamental to how advanced semiconductors are made, which is why each quarterly result gives investors a useful read on…

ByCharlie YouldenApril 16, 2026

Stars And Stripes Income: The 6 Best American stocks for Australian investors in 2026!

Stocks Down Under recaps tha Best American stocks for Australian investors! We know that many Australian investors look beyond the ASX for opportunities, and US equities remain the deepest and most liquid market in the world. What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Practical considerations for investors…

ByNick SundichApril 15, 2026

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

The ASX's 3 pathology stocks: Sonic Healthcare (ASX:SHL), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL); have delivered a torrid experience for shareholders over the past two to three years. Sonic, the global heavyweight, has fallen nearly 20% since early 2025 and recently traded at decade lows. Healius, long the sector’s problem child, has lost more than…

ByNick SundichApril 15, 2026

the Kick-ass Multipurpose WordPress Theme

Blue Chip Stocks

How To Read a Balance Sheet As An Investor: The 7 Questions Prudent Investors Need to Ask!

Its Deja Vu For Big Four Bank Investors As The Mortgage Wars Recommence With a Vengence!

Phase 1 of The ASX’s CHESS System Went Live Without a Hitch! But Unfortunately, The Job’s Not Done Just Yet

Omni Bridgeway (ASX:OBL): Up 20% This Year Off The Back of Litigation Financing!

Are These 10 ASX Stocks With Low PE Multiples Buying Opportunities?

The Chinese Economy In 2026 Has Vastly Changed Compared to Years Gone By: Here’s What It Means for the ASX!

These 8 ASX Growth Stocks Have High P/Es

ASML (NASDAQ:ASML) Q1 sales +15%, but system shipments slowed and stock fell 7%

Stars And Stripes Income: The 6 Best American stocks for Australian investors in 2026!

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Blue Chip Stocks

Stocks in Spotlight

Add Your Heading Text Here